Showing all 13 results
Acenocoumarol Tablets
FreeProduct Composition & Strength
We supply this product in multiple strengths to allow for the precise, micro-gram level titration required for safe anticoagulation.
Active Ingredient Strength Primary Clinical Function Acenocoumarol USP/BP/Ph.Eur. 1 mg / 2 mg The Titration Unit: Used for fine-tuning the maintenance dose to keep the INR within the target range (usually 2.0–3.0). Acenocoumarol USP/BP/Ph.Eur. 3 mg / 4 mg The Loading/Anchor Dose: Used for initial therapy or for patients requiring higher systemic anticoagulation. Excipients Proprietary Matrix Bio-Stable System: Engineered to ensure consistent oral absorption and predictable pharmacokinetics. Acetyl Salicylic Acid Tablets
FreeProduct Composition & Strength
We supply this product in two distinct clinical ranges: the “Cardio-Shield” range and the “Analgesic-Power” range.
Active Ingredient Strength Primary Clinical Function Acetylsalicylic Acid USP/BP 75 mg / 100 mg The Cardio-Shield: Once-daily “Baby Aspirin” for long-term prevention of heart attack and stroke. Acetylsalicylic Acid USP/BP 300 mg The Emergency Loading Dose: Used immediately during a suspected heart attack to break up clots. Acetylsalicylic Acid USP/BP 500 mg The Analgesic Anchor: For the relief of headache, toothache, and musculoskeletal pain. Amiloride & Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product in the globally standardized strength ratio, packed in high-barrier Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Amiloride (as HCl) USP/BP 5 mg The Potassium Guard: Prevents the loss of potassium, protecting against heart arrhythmias and muscle weakness. Hydrochlorothiazide USP/BP 50 mg The Volume Reducer: Excretes excess sodium and water to reduce the load on the heart and vessels. Excipients Proprietary Matrix Steady-State Release System: Engineered to ensure a consistent diuretic effect over a full 24-hour cycle. Amlodipine & Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, engineered for synchronized 24-hour hemodynamic control.
Active Ingredient Strength Primary Clinical Function Amlodipine (as Besylate) USP/BP 5 mg / 10 mg The Vasodilator: Reduces the resistance of blood vessels to lower systemic pressure. Hydrochlorothiazide USP/BP 12.5 mg / 25 mg The Volume Reducer: Excretes excess sodium and water to reduce circulatory load. Excipients Proprietary Matrix Steady-State System: Engineered to ensure consistent plasma concentrations of both drugs to prevent “dips” in BP control. Apixaban Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Apixaban USP/Ph.Eur. 2.5 mg The Dose-Reduction Unit: Used for patients with specific risk factors (Age ≥80, Weight ≤60kg, or high Creatinine) to minimize bleeding. Apixaban USP/Ph.Eur. 5 mg The Therapeutic Anchor: The standard maintenance dose for stroke prevention in Atrial Fibrillation and DVT treatment. Excipients Proprietary Matrix Rapid-Dissolution System: Engineered to ensure a consistent $T_{max}$ of approx. 3 to 4 hours for reliable protection. Aspirin Tablets
FreeProduct Composition & Strength
We supply this product in various formats, including Gastro-resistant (Enteric-coated), Dispersible, and standard Film-coated tablets.
Active Ingredient Strength Primary Clinical Function Aspirin (Acetylsalicylic Acid) 75 mg / 81 mg The Cardiac Shield: Low-dose daily therapy for the prevention of heart attack and stroke. Aspirin (Acetylsalicylic Acid) 150 mg Post-Surgical Maintenance: Used for patients with stents or high-risk vascular profiles. Aspirin (Acetylsalicylic Acid) 300 mg / 500 mg The Analgesic Anchor: High-dose relief for acute pain, migraine, and rheumatic fever. Atenolol & Indapamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, engineered for synchronized 24-hour hemodynamic control.
Active Ingredient Strength Primary Clinical Function Atenolol USP/BP 50 mg The Heart Rate Regulator: Controls cardiac output and myocardial oxygen demand. Indapamide USP/BP 2.5 mg The Metabolic-Neutral Diuretic: Reduces blood volume and provides direct vascular relaxation. Excipients Proprietary Matrix Steady-State Release System: Engineered to ensure consistent plasma concentrations of both drugs to prevent “dips” in BP control. Atenolol & S-Amlodipine Besylate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, utilizing high-purity S-Amlodipine Besylate to ensure stability.
Active Ingredient Strength Primary Clinical Function Atenolol USP/BP 25 mg / 50 mg The Heart Rate Regulator: Controls the “Pump” by reducing heart rate and myocardial oxygen demand. S-Amlodipine (as Besylate) USP/BP 2.5 mg / 5 mg The Vessel Relaxant: Pure chiral isomer for maximum vasodilation with minimum side effects (edema). Excipients Proprietary Matrix Chiral-Stability System: Engineered to ensure the S-enantiomer remains stable and does not racemize during the shelf-life. Atorvastatin & Aspirin and Clopidogrel Tablets
FreeProduct Composition & Strength
We supply this product typically in a Capsule-in-Capsule or Multi-Particulate Tablet format to ensure the chemical stability of the three distinct APIs.
Active Ingredient Strength Primary Clinical Function Atorvastatin (as Calcium) USP 10 mg / 20 mg The Lipid Stabilizer: Lowers cholesterol and prevents the growth of arterial blockages. Aspirin (Gastro-resistant) BP 75 mg / 150 mg The Primary Blood Thinner: Prevents initial platelet activation via the COX pathway. Clopidogrel (as Bisulphate) USP 75 mg The Secondary Blood Thinner: Provides high-level protection against stent thrombosis and recurrent stroke. Atorvastatin & Asprin Tablets
FreeProduct Composition & Strength
We supply this product as a Bi-Layered or Film-Coated Tablet, often utilizing specialized enteric coating for the Aspirin component to protect the stomach lining.
Active Ingredient Strength Primary Clinical Function Atorvastatin Calcium USP/BP 10 mg / 20 mg The Lipid Regulator: Controls cholesterol synthesis in the liver and stabilizes arterial walls. Aspirin (Gastro-resistant) BP 75 mg / 150 mg The Anti-Platelet Anchor: Provides low-dose blood thinning to prevent clot formation. Excipients Proprietary Matrix Gastro-Protective System: Engineered to ensure Aspirin dissolves only in the small intestine, minimizing gastric irritation. Azilsartan Medoxomil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in moisture-resistant Alu-Alu blister strips to ensure the stability of the Medoxomil ester.
Active Ingredient Strength Primary Clinical Function Azilsartan Medoxomil Potassium 40 mg The Standard Initiation Unit: The primary starting dose for most adult patients with hypertension. Azilsartan Medoxomil Potassium 80 mg The High-Potency Payload: For patients requiring additional blood pressure lowering beyond the 40 mg dose. Excipients Proprietary Matrix Hydrolysis-Stable System: Engineered to prevent premature breakdown of the prodrug before it reaches the gastrointestinal tract. Benzthiazide & Triamterene Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Disintegration Tablet, packed in high-barrier Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Benzthiazide USP/BP 25 mg The Thiazide Payload: The primary driver for sodium and water excretion to lower blood pressure. Triamterene USP/BP 50 mg The Potassium Guardian: Physically prevents the loss of Potassium (K+) during the diuretic process. Excipients Proprietary Matrix Bio-Balance System: Engineered to ensure synchronized dissolution of both active APIs for maximum clinical synergy. Bosentan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in moisture-resistant Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Bosentan (as Monohydrate) USP/Ph.Eur. 62.5 mg The Initiation Unit: Utilized for the first 4 weeks of therapy to assess patient tolerance and liver response. Bosentan (as Monohydrate) USP/Ph.Eur. 125 mg The Maintenance Payload: The standardized therapeutic dose for long-term management of PAH and exercise capacity improvement. Excipients Proprietary Matrix Controlled Disintegration System: Engineered to ensure a predictable pharmacokinetic profile, matching the innovator brand’s $T_{max}$ (time to peak concentration).
